(Q34212223)

31 July 2017

1 reference

title

Obesity and weight loss in polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

31 July 2017

0 references

1 reference

1 reference

Hoeger K

1

1 reference

31 July 2017

language of work or name

1 reference

1 March 2001

1 reference

Obstetrics and Gynecology Clinics of North America

31 July 2017

published in

1 reference

31 July 2017

volume

28

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

85-97, vi-vii

1 reference

Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Insulin action in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Overweight and obesity in the United States: prevalence and trends, 1960-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Relation of body fat distribution to metabolic complications of obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Influences of weight, body fat patterning and nutrition on the management of PCOS.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

The genetics of obesity. Lessons for polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Metabolic profiles and lipoprotein lipid concentrations in non-obese and obese patients with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

A prospective study of obesity and risk of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

1 reference

7 January 2021

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Health implications of overweight and obesity in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

The Effects on Plasma Lipoproteins of a Prudent Weight-Reducing Diet, with or without Exercise, in Overweight Men and Women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

Endocrine comparison of obese menstruating and amenorrheic women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970187-X

7 January 2021

10.1016/S0889-8545(05)70187-X

Identifiers

DOI

1 reference

31 July 2017

1 reference